| Literature DB >> 30554962 |
Asaf Zviran1, Nofar Mor2, Yoach Rais3, Hila Gingold2, Shani Peles2, Elad Chomsky4, Sergey Viukov2, Jason D Buenrostro5, Roberta Scognamiglio6, Leehee Weinberger2, Yair S Manor2, Vladislav Krupalnik2, Mirie Zerbib2, Hadas Hezroni7, Diego Adhemar Jaitin8, David Larastiaso8, Shlomit Gilad9, Sima Benjamin9, Ohad Gafni2, Awni Mousa2, Muneef Ayyash2, Daoud Sheban10, Jonathan Bayerl2, Alejandro Aguilera-Castrejon2, Rada Massarwa2, Itay Maza11, Suhair Hanna12, Yonatan Stelzer13, Igor Ulitsky7, William J Greenleaf14, Amos Tanay15, Andreas Trumpp6, Ido Amit8, Yitzhak Pilpel2, Noa Novershtern16, Jacob H Hanna17.
Abstract
The epigenetic dynamics of induced pluripotent stem cell (iPSC) reprogramming in correctly reprogrammed cells at high resolution and throughout the entire process remain largely undefined. Here, we characterize conversion of mouse fibroblasts into iPSCs using Gatad2a-Mbd3/NuRD-depleted and highly efficient reprogramming systems. Unbiased high-resolution profiling of dynamic changes in levels of gene expression, chromatin engagement, DNA accessibility, and DNA methylation were obtained. We identified two distinct and synergistic transcriptional modules that dominate successful reprogramming, which are associated with cell identity and biosynthetic genes. The pluripotency module is governed by dynamic alterations in epigenetic modifications to promoters and binding by Oct4, Sox2, and Klf4, but not Myc. Early DNA demethylation at certain enhancers prospectively marks cells fated to reprogram. Myc activity drives expression of the essential biosynthetic module and is associated with optimized changes in tRNA codon usage. Our functional validations highlight interweaved epigenetic- and Myc-governed essential reconfigurations that rapidly commission and propel deterministic reprogramming toward naive pluripotency.Entities:
Keywords: Gatad2a; Mbd3; Myc; NuRD; deterministic reprogramming; epigenetics; epigenomics; iPSC; pluripotency
Mesh:
Substances:
Year: 2018 PMID: 30554962 PMCID: PMC7116520 DOI: 10.1016/j.stem.2018.11.014
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633